相关实验视频
Updated: Jun 22, 2025

10:14
Recapitulation of an Ion Channel IV Curve Using Frequency Components
Published on: February 8, 2011
13.5K
动态药物-hERG通道相互作用的实验验验证建模,重现结合机制及其在作用潜力持续时间中的重要性
Fernando Escobar1, Soren Friis2, Nouran Adly2
1Centro de Innovación e Investigación en Bioingeniería, Universitat Politècnica de València, Valencia, Spain.
Computer methods and programs in biomedicine
|June 27, 2024
概括
这项研究验证了一种新的动态建模方法,通过准确预测与hERG通道的药物相互作用来评估药物心脏毒性. 这些发现强调了动态建模对于理解药物对心脏作用潜力的作用的重要性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 计算生物学 计算生物学
- 心血管研究研究心血管研究
背景情况:
- 药物诱导的心脏毒性是制药开发中的一个主要问题.
- 对hERG通道的药物结合动态建模有助于早期心脏毒性评估.
- 之前的工作建立了药物与hERG相互作用的马科维模型的方法.
研究的目的:
- 通过使用真实IKr阻断器验证先前开发的马科维模型方法.
- 调查药物动态对作用潜力的延长的影响.
- 将动态模型与静态模型和现有的CiPA动态模型进行比较.
主要方法:
- 使用Nanion SyncroPatch 384i,使用了稳定感染hERG的HEK细胞.
- 三个电压协议 (P-80,P0,P40) 被应用来收集实验数据.
- 创建了马科维亚模型和静态模型;使用修改的奥哈拉-鲁迪模型模拟了动作潜力的持续时间.
主要成果:
- 获得了10种IKr阻断剂的实验数据,包括Hill图和IKr阻断的开始.
- 生成的动态马科维亚模型成功地模仿了实验数据,超过了CiPA动态模型.
- 模拟显示了动态模型和静态模型之间动作潜能持续时间延长的显著差异.
结论:
- 这项研究验证了一种用于建模动态药物-hERG通道相互作用的方法.
- 国家依赖的结合,捕获动态和IKr块的时间过程对于评估药物效应至关重要.
- 动态模型对于准确预测心脏电生理学中药物诱导的变化至关重要.
相关概念视频
Ligand-gated Ion Channels
12.4K
Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
12.4K
Voltage-gated Ion Channels
8.2K
Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
8.2K
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models
77
Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
77
Pharmacokinetic Models: Comparison and Selection Criterion
66
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
66
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.3K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.3K
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
38
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
38

